Following the 1992 promulgation on Protection of Traditional Chinese Medicine Regulations”, 267 varieties of traditional Chinese medicines were protected. Five areas, namely respiratory medicine, medicine for the cardiovascular system, for the digestive system, for the genitourinary system and sex hormone drugs, and for the musculoskeletal system, account for 90.2% of all 267 varieties. Following the Outline of the National Strategic Plan for Intellectual Property (2016-2030), the Outline of the Healthy China 2030 Plan and the Strategic Plan for the Development of Traditional Chinese Medicine (2016-2030), CFDA has recently announced that new regulations on TCM will be shortly announced which will cover IP, manufacturing processes etc.”
China Bio news release, February 9 2017